Company registration number SC391911 (Scotland)
BALGILLO NURSERIES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
BALGILLO NURSERIES LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
BALGILLO NURSERIES LIMITED
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
4
57,953
71,734
Current assets
Debtors
5
216,120
263,930
Creditors: amounts falling due within one year
6
(150,595)
(92,132)
Net current assets
65,525
171,798
Total assets less current liabilities
123,478
243,532
Creditors: amounts falling due after more than one year
7
-
0
(57,987)
Net assets
123,478
185,545
Capital and reserves
Called up share capital
9
100
100
Profit and loss reserves
123,378
185,445
Total equity
123,478
185,545

For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 30 June 2026
Mrs P S Gall
Director
Company registration number SC391911 (Scotland)
BALGILLO NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
- 2 -
1
Accounting policies
Company information

Balgillo Nurseries Limited is a private company limited by shares incorporated in Scotland. The registered office is 56 Torridon Road, Broughty Ferry, Dundee, Scotland, DD5 3HB.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Tenants improvements
10% straight line
Plant and machinery
25% reducing balance
Equipment
25% reducing balance
Motor vehicles
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

BALGILLO NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 3 -
1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

1.8
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

BALGILLO NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 4 -
1.9
Leases
As lessee

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
18
17
4
Tangible fixed assets
Tenants improvements
Plant and machinery
Equipment
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 April 2025
40,163
9,291
8,066
99,110
156,630
Disposals
-
0
(9,291)
(1,028)
-
0
(10,319)
At 31 March 2026
40,163
-
0
7,038
99,110
146,311
Depreciation and impairment
At 1 April 2025
18,583
7,821
5,297
53,195
84,896
Depreciation charged in the year
3,083
-
0
667
8,458
12,208
Eliminated in respect of disposals
-
0
(7,821)
(925)
-
0
(8,746)
At 31 March 2026
21,666
-
0
5,039
61,653
88,358
BALGILLO NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
4
Tangible fixed assets
Tenants improvements
Plant and machinery
Equipment
Motor vehicles
Total
£
£
£
£
£
(Continued)
- 5 -
Carrying amount
At 31 March 2026
18,497
-
0
1,999
37,457
57,953
At 31 March 2025
21,580
1,470
2,769
45,915
71,734
5
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
322
39,308
Other debtors
215,798
224,622
216,120
263,930
6
Creditors: amounts falling due within one year
2026
2025
£
£
Bank loans and overdrafts
8,180
15,079
Trade creditors
94
-
0
Taxation and social security
23,412
31,266
Other creditors
118,909
45,787
150,595
92,132
7
Creditors: amounts falling due after more than one year
2026
2025
£
£
Other creditors
-
0
57,987
8
Finance lease obligations
2026
2025
Amounts due:
£
£
Within one year
57,987
12,256
After more than one year
-
0
57,987
57,987
70,243
BALGILLO NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
8
Finance lease obligations
(Continued)
- 6 -
2026
2025
Future minimum lease payments due:
£
£
Within one year
57,987
12,256
In two to five years
-
0
57,987
57,987
70,243

 

9
Called up share capital
2026
2025
2026
2025
Ordinary share capital
Number
Number
£
£
Issued and fully paid
of £1 each
100
100
100
100
2026-03-312025-04-01falsefalsefalse30 June 2026CCH SoftwareCCH Accounts Production 2026.200No description of principal activityMrs P S GallSC3919112025-04-012026-03-31SC3919112026-03-31SC391911core:WithinOneYear2026-03-31SC391911core:WithinOneYear2025-03-31SC391911core:CurrentFinancialInstrumentscore:WithinOneYear2026-03-31SC391911core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-31SC391911core:Non-currentFinancialInstrumentscore:AfterOneYear2026-03-31SC391911core:Non-currentFinancialInstrumentscore:AfterOneYear2025-03-31SC3919112025-03-31SC391911core:ShareCapital2026-03-31SC391911core:ShareCapital2025-03-31SC391911core:RetainedEarningsAccumulatedLosses2026-03-31SC391911core:RetainedEarningsAccumulatedLosses2025-03-31SC391911core:ShareCapitalOrdinaryShareClass12026-03-31SC391911core:ShareCapitalOrdinaryShareClass12025-03-31SC391911bus:Director12025-04-012026-03-31SC391911core:LeaseholdImprovements2025-04-012026-03-31SC391911core:PlantMachinery2025-04-012026-03-31SC391911core:ComputerEquipment2025-04-012026-03-31SC391911core:MotorVehicles2025-04-012026-03-31SC3919112024-04-012025-03-31SC391911core:LeaseholdImprovements2025-03-31SC391911core:PlantMachinery2025-03-31SC391911core:ComputerEquipment2025-03-31SC391911core:MotorVehicles2025-03-31SC3919112025-03-31SC391911core:LeaseholdImprovements2026-03-31SC391911core:PlantMachinery2026-03-31SC391911core:ComputerEquipment2026-03-31SC391911core:MotorVehicles2026-03-31SC391911core:LeaseholdImprovements2025-03-31SC391911core:PlantMachinery2025-03-31SC391911core:ComputerEquipment2025-03-31SC391911core:MotorVehicles2025-03-31SC391911core:CurrentFinancialInstruments2026-03-31SC391911core:CurrentFinancialInstruments2025-03-31SC391911core:Non-currentFinancialInstruments2026-03-31SC391911core:Non-currentFinancialInstruments2025-03-31SC391911core:BetweenTwoFiveYears2026-03-31SC391911core:BetweenTwoFiveYears2025-03-31SC391911bus:OrdinaryShareClass12025-04-012026-03-31SC391911bus:OrdinaryShareClass12026-03-31SC391911bus:OrdinaryShareClass12025-03-31SC391911bus:PrivateLimitedCompanyLtd2025-04-012026-03-31SC391911bus:SmallCompaniesRegimeForAccounts2025-04-012026-03-31SC391911bus:FRS1022025-04-012026-03-31SC391911bus:AuditExemptWithAccountantsReport2025-04-012026-03-31SC391911bus:FullAccounts2025-04-012026-03-31xbrli:purexbrli:sharesiso4217:GBP